30 devices · GMDN 57275
Hepatocyte-specific antigen IVD antibody tests detect proteins uniquely expressed in liver cells, aiding in the diagnosis of liver-related conditions like hepatocellular carcinoma or liver damage. Clinically, these assays help differentiate malignant liver tumors from benign lesions by identifying specific markers tied to hepatocyte activity.
These devices are typically in-vitro diagnostics (IVDs) regulated under strict standards for accuracy and safety, often requiring validation for clinical use. They may be supplied as kits, reagents, or ready-to-use reagents, depending on the manufacturer’s design and intended workflow.
This category summary is AI-generated from the GMDN nomenclature and has not been verified by a human reviewer.